NEOGENOMICS INC — Director's Dealing 2022

Aug 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-08-01

Reporting Person: Kulkarni Shashikant (President of Lab Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-01	Common Stock	A	24704	—	Acquired	65856	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-01	Stock Option (Right to Buy)	$10.12	A	51653	Acquired	2029-08-01	Common Stock (51653.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$12.15	2029-04-01	Common Stock (88496.0)	88496	Direct

Footnotes

F1: On August 1, 2022, Dr. Kulkarni was granted 24,704 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.

F2: On April 1, 2022, Dr. Kulkarni was granted 88,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F3: On August 1, 2022, Dr. Kulkarni was granted 51,653 stock options. These options vest ratably over the first four anniversary dates of the grant date.